Kiniksa Pharmaceuticals International
KNSA
93.90
+0.36
+0.38%
Kiniksa Pharmaceuticals International
US · KNSA
#1938 by market cap
Listed 2018
93.90
+0.36
+0.38%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Kiniksa Pharmaceuticals International
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
- Founded
- 2024
- CEO
- Mr. Sanj K. Patel
- Employees
- 366
- Headquarters
- London, Greater London, United Kingdom of Great Britain and Northern Ireland (the)
- Fiscal year end
- 12-31
- Website
- kiniksa.com
Company profile
- Exchange
- US
- Symbol
- KNSA
- Market-cap rank
- #1938
- Listing date
- 2018-05-24
- Market cap
- 7.38B
- Float cap
- 4.18B
- Shares out
- 78.57M
- Float shares
- 44.56M
Sectors & themes
Drug Manufacturers - Specialty & Generic
Fractional Shares JP
Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Kiniksa Pharmaceuticals International discussion 0 comments